SARAH ALDOR: Open Payments
NPI 1487930699 · TUCSON, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$512 in 28 payments from 8 companies in 2025. Trend: 2023 $278 · 2024 $1,346 · 2025 $512
Food & beverage: $446Education: $66
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 16 | $268 |
| Galderma Laboratories, L.P. | 5 | $90 |
| Novartis Pharmaceuticals Corporation | 2 | $50 |
| KYOWA KIRIN, INC. | 1 | $29 |
| Regeneron Healthcare Solutions, Inc. | 1 | $21 |
| Lilly USA, LLC | 1 | $19 |
| Amgen Inc. | 1 | $19 |
| PFIZER INC. | 1 | $16 |
Products named: TREMFYA, NEMLUVIO, COSENTYX, POTELIGEO, LIBTAYO, EBGLYSS, OTEZLA, CIBINQO.
Industry payments across AZ — which companies pay providers there.
